BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Apr 25, 2011
 |  BC Week In Review  |  Company News  |  Deals

ChronTech, Inovio, Transgene deal

The companies partnered to conduct a Phase I trial to evaluate ChronTech's ChronVac-C plasmid DNA vaccine as a prime and Transgene's TG4040 vaccine as a boost to...

Read the full 132 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >